Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Edwards’ Pursuit Of Transcatheter Mitral Valve Repair Options Continues, CEO Says

This article was originally published in The Gray Sheet

Executive Summary

During the recent Wilson Sonsini Goodrich & Rosati Medical Device Conference in San Francisco, Edwards Lifesciences CEO Michael Mussallem offered candid remarks on his firm’s continued interest in developing a minimally invasive mitral valve repair product.

Advertisement

Related Content

TAVR Competitors Put Pressure On Edwards To Deliver On New Growth Drivers
FDA Advisory Panel Will Evaluate Abbott’s MitraClip Next Month
New Products In Brief
Sapien Heart Valve Gets FDA Panel Nod For High-Risk Surgical Patients

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT031348

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel